New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
17:32 EDTMPC, BCR, FOSL, FASTSAC Capital reports new stakes in Fossil, Marathon, Fastenal, C.R. Bard
News For FOSL;MPC;FAST;BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 28, 2014
06:23 EDTMPCOPEC maintains production level to restore 'market equilibrium'
The Organization of the Petroleum Exporting Countries said in a press release following its meeting yesterday, "Recording its concern over the rapid decline in oil prices in recent months, the Conference concurred that stable oil prices – at a level which did not affect global economic growth but which, at the same time, allowed producers to receive a decent income and to invest to meet future demand – were vital for world economic wellbeing. Accordingly, in the interest of restoring market equilibrium, the Conference decided to maintain the production level of 30.0 mb/d, as was agreed in December 2011. As always, in taking this decision, Member Countries confirmed their readiness to respond to developments which could have an adverse impact on the maintenance of an orderly and balanced oil market." Publicly traded companies in the refining space include Delek US (DK), HollyFrontier (HFC), Marathon Petroleum (MPC), Phillips 66 (PSX), Tesoro (TSO), Valero (VLO) and Western Refining (WNR). Publicly traded companies in the oil space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Stocks globally are trading lower Friday following OPEC's decision.
November 26, 2014
14:28 EDTBCRMedtronic agrees to divest Covidien drug-coated balloon catheter business
Medtronic (MDT) has agreed to divest the drug-coated balloon catheter business of Covidien (COV) in order to settle Federal Trade Commission charges that its $42.9B acquisition of Covidien would likely be anticompetitive. Under the FTC’s proposed settlement, Medtronic will sell the drug-coated balloon catheter business to medical device company Spectranetics (SPNC), the FTC announced. According to the FTC’s complaint both Medtronic and Covidien are developing drug-coated balloon catheters to compete with C.R. Bard (BCR), which currently is the only company that supplies these products, used to treat peripheral artery disease, in the U.S. market. Medtronic and Covidien are the only companies with products in clinical trials in the Food and Drug Administration’s approval process, which makes it unlikely that other competitors could enter the market in time to counteract the effects of the merger, the FTC alleges. The Commission vote to accept the proposed consent order for public comment was 5-0. The FTC will publish the consent agreement package in the Federal Register shortly. The agreement will be subject to public comment for 30 days, beginning today and continuing through December 29, after which the Commission will decide whether to make the proposed consent order final.
November 21, 2014
10:20 EDTFASTHigh option volume stocks
Subscribe for More Information
November 18, 2014
10:20 EDTFOSLOptions with decreasing implied volatility
Subscribe for More Information
09:56 EDTMPCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:50 EDTMPCCST Brands should be acquistion target for Marathon, CNBC's Cramer says
On Jim Cramer's "Mad Money" broadcast Monday, the host made the case for why Marathon Petroleum (MPC) should buy CST Brands (CST), according to a show recap posted by TheStreet. Shares of CST Brands are up 3.4% to $43.35 in pre-market trading. Reference Link
06:30 EDTMPCMarathon Petroleum coverage resumed with a Buy at Goldman
Target $127.
November 17, 2014
12:03 EDTFOSLOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use